Keywords
Long-acting reversible contraceptives
Intrauterine device
Intrauterine system
Subdermal implant
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To assess Brazilian women's understanding of long-acting reversible contraceptives (LARCs). Methods: An observational study was conducted with 100 volunteers, women over 18 years old from the state of São Paulo, using an online form with 18 questions. Data were collected randomly through social media between 03/03/22 and 31/03/22. Results: Analyzing responses from 100 women, it was observed that 24% use LARCs, predominantly in the private healthcare system (19%) compared to the public system (4%). Knowledge about LARCs significantly correlated with medical recommendations (p=0.00005). Among those familiar with LARCs, 45 received medical suggestions. Fear of side effects (34%), lack of knowledge (26%), and cost (20%) were reasons cited for not using LARCs. Of the 24 women using LARCs, 21 (87.5%) had a positive experience, while 4 (16.7%) reported a negative experience. Conclusion: The study reveals low awareness of LARCs, especially among women in the public healthcare system. Medical recommendations were crucial for usage. Barriers such as fear of side effects and cost were identified. Positive experiences suggest that demystifying information can increase acceptance. Lack of access to information and medical guidance are challenges to overcome in promoting more informed contraceptive choices.
References
ARAÚJO FG, et al. Mix contraceptivo e fatores associados ao tipo de método usado pelas mulheres brasileiras: estudo transversal de base populacional. Cad Saúde Pública [Internet], 2023; 39(8): e00229322.
BAHAMONDES L, et al. Long-acting reversible contraceptive (LARCs) methods. Best Pract Res Clin Obstet Gynaecol, 2020; 66: 28-40.
BAPTISTA VF. A pílula contraceptiva na ótica da religião: observando a Pesquisa Nacional de Demografia e Saúde da Criança e da Mulher (PNDS-2006). Research, Society and Development, 2021; 10(10): e495101019289.
BLUMENBERG C, et al. Socio-demographic and economic inequalities in modern contraception in 11 low- and middle-income countries: an analysis of the PMA2020 surveys. Reprod Health, 2020; 17(1): 82.
BRANDÃO ER e CABRAL CD. From unplanned pregnancy to contraception: contributions to the debate. Cad Saúde Pública, 2017; 33(2): e00211216.
BRASIL. Portaria nº 3.265, de 1ºde Dezembro de 2017. Dispõe sobre a ampliação do acesso ao Dispositivo Intrauterino Tcu 380 (DIU de cobre) no âmbito do Sistema Único de Saúde (SUS). Disponível em: <https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt3265_07_12_2017.html> Acesso em 11/12/2023.
CAFFE S, et al. Looking back and moving forward: can we accelerate progress on adolescent pregnancy in the Americas? Reprod Health, 2017; 14(1): 83.
CHRISTOFIELD M, LACOSTE M. Accessible contraceptive implant removal services: an essential element of quality service delivery and scale-up. Glob Health Sci Pract, 2016; 4: 366–372.
DARNEY BG, et al. US “safety net” clinics provide access to effective contraception for adolescents and young women, 2017–2019. Am J Public Health, 2022a; 112: S555–S562.
DARNEY BG, et al. Title X improved access to most effective and moderately effective contraception in US safety-net clinics, 2016–18. Health Aff (Millwood), 2022b; 41: 497–506.
EECKHAUT MCW, et al. Who Is Using Long-Acting Reversible Contraceptive Methods? Findings from Nine Low-Fertility Countries. Perspectives on Sexual and Reproductive Health, 2014; 46(3):149–155.
ELA EJ, et al. Satisfaction, resignation, and dissatisfaction with long-acting reversible contraception among low-income postpartum Texans. Womens Health Issues, 2022; 32: 334–342.
EWERLING F, et al. Demand for family planning satisfied with modern methods among sexually active women in low- and middle-income countries: who is lagging behind? Reprod Health, 2018; 15(1): 1–10.
FAGAN T, et al. Family Planning in the Context of Latin America's Universal Health Coverage Agenda. Glob Health Sci Pract, 2017; 5(3): 382-398.
FEBRASGO. Contracepção reversível de longa ação. - - São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia, 2022. (Série Orientações e Recomendações FEBRASGO, no. 1/Comissão Nacional Especializada em Anticoncepção). ii, 44p [cited 2023 Mar Available from: https://www.febrasgo.org.br/media/k2/attachments/03-CONTRACEPCAO_REVERSIVEL_DE_LONGA_ACAO.pdf.
GANATRA B, et al. Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model. Lancet, 2017; 390(10110): 2372-2381.
GRADY WR, et al. Contraceptive method switching in the United States. Perspect Sex Reprod Health 2002; 34: 135–145.
GUPTE PR. India: “The Emergency” and the politics of mass sterilization. Educ About Asia, 2017; 22(3): 40–44.
HENRY D, et al. Facilitators and Barriers to Implementation of Long-Acting Reversible Contraceptive Services for Adolescent Girls and Young Women in Gaborone, Botswana. Journal of Pediatric and Adolescent Gynecology. 2021; 34(4): 504-513.
JACINTO A, et al. Introducing long-acting contraceptive removal indicators in a pilot study in Mozambique: dynamics of discontinuation and implications for quality of care. Glob Health Sci Pract, 2022; 10: e2100252.
JACKSON E, GLASIER A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol, 2011; 117: 657-662.
JONES RK, et al. Contraceptive use among U.S. women having abortions in 2000-2001. Perspect Sex Reprod Health, 2002; 34(6): 294-303.
MACHADO RB, et al. Long-Acting Reversible Contraception. Rev Bras Ginecol Obstet [Internet], 2017; 39(6): 294–308.
MACHADO RB, et al. Different perceptions among women and their physicians regarding contraceptive counseling: results from the TANCO Survey in Brazil. Rev Bras Ginecol Obstet, 2020; 42(5): 255-265.
MAVRANEZOULI I. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline. Human Reproduction, 2008; 23(6), 1338–1345.
MINISTÉRIO DA SAÚDE. NT-DIU NOTA TÉCNICA Nº 21/2021-DAPES/SAPS/MS. inserção do Dispositivo Intrauterino e Contraceptivo (DIU) por enfermeiros. Brasília: Ministério da Saúde, Secretaria de Gestão do Trabalho e da Educação na Saúde, Departamento de Gestão da Educação em Saúde; 2021 Out. Disponível em: https://egestorab.saude.gov.br/image/?file=20211029_N_NTDIUenfermagem_5214792097250368643.pdf. Acesso em: 11/12/2023.
PANIZ VMV, et al. Conhecimento sobre anticoncepcionais em uma população de 15 anos ou mais de uma cidade do Sul do Brasil. Cad Saúde Pública [Internet], 2005; 21(6): 1747–1760.
PEIPERT JF, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol, 2011; 117: 1105–1113.
PONCE DE LEON RG, et al. Contraceptive Use in 23 Countries in Latin America and the Caribbean: Long-Acting Reversible Contraceptives Much Less Popular than Short-Acting Contraceptives. SSRN Electronic Journal, 2018; 7(2): e227–e235.
PONCE DE LEON RG, et al. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries. Lancet Glob Health, 2019; 7(2): e227–e235.
POLIS CB, et al. Typical-use contraceptive failure rates in 43 countries with Demographic and Health Survey data: summary of a detailed report. Contraception, 2016; 94(1): 11-17.
SAAVALA M. Understanding the prevalence of female sterilization in rural South India. Stud Fam Plann, 1999; 30(4): 288–301.
SHARMA DC. India’s sterilisation scandal. Lancet, 2014; 384(9961): e68–e69.
SIMMONS RG, et al. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants. Am J Obstet Gynecol, 2019; 220(4): 376.e1-376.e12.
SZNAJDER KK, et al. Incidence of discontinuation of long-acting reversible contraception among adolescent and young adult women served by an urban primary care clinic. J Pediatr Adolesc Gynecol, 2017; 30: 53–57.
TONG YW, et al. Acceptability of different mechanisms of action of contraception in women: a questionnaire survey. BMJ Sex Reprod Health, 2022; 48(2): 117-122.
TRUSSELL J. Contraceptive failure in the United States. Contraception, 2011; 83(5): 397-404.
UGAZ JI, et al. Regional trends in the use of short-acting and long-acting contraception accessed through the private and public sectors. Int J Gynaecol Obstet, 2015;130 Suppl 3: E3-7.
WENDER MCO, et al. Influência da utilização de métodos contraceptivos sobre as taxas de gestação não planejada em mulheres brasileiras. Femina, 2022; 50(3): 134-141.
WYATT KD, et al. Women’s values in contraceptive choice: a systematic review of relevant attributes included in decision aids. BMC Womens Health, 2014; 14(1): 28.